Gates Foundation Diverts Money To Vaccine Manufacturers Whilst Failing The Children

[Guest guest]

Gates Foundation Diverts Money To Vaccine Manufacturers Whilst Failing The

Children

http://www.theoneclickgroup.co.uk/news.php?start=2720 & end=2740 & view=yes & id=3529#\

newspost

McCoy and colleagues1 note that half of all Gates Foundation funding goes

towards vaccination. The advance marketing commitments for pneumococcal vaccine

illustrate the problem with this policy quite lucidly. Madhi and colleagues3

have calculated that 1000 children have to be vaccinated to prevent

approximately four cases of pneumonia. Given that the vaccine costs $250 per

child, $250 000 will be spent to prevent these four cases of pneumonia.

Treatment of four children with pneumonia with oral cotrimoxazole, in accordance

with the WHO protocol,4 will cost $1 in India. The hope that GAVI’s funding of

vaccines would push down their prices has been belied.. One review found that

prices actually went up after GAVI funding,5 meaning that the higher costs are

borne by poor nations when GAVI funding is withdrawn. Entering into advance

commitments to market this vaccine in developing countries allows GAVI to divert

Gates Foundat ion money to vaccine

manufacturers, without providing commensurate benefits to the children it is

supposed to help.

Gopal Dabade, Puliyel

57 Tejaswinagar, Dharwad, India (GD); and St s Hospital, Delhi 110054,

India (JP)/Vol 373 June 27, 2009, The Lancet

Related